INFIQ·45665G303·US·equity·Healthcare - Biotechnology
INFIQ (INFINITY PHARMACEUTICALS INC) is held by 0 institutional investors as of Q4 2023. Net institutional sentiment: Bearish.
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer